Literature DB >> 9718197

Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids.

P R Ebeling1, B Erbas, J L Hopper, J D Wark, A R Rubinfeld.   

Abstract

Inhaled glucocorticoids are pivotal in maintenance therapy of chronic bronchial asthma; however, conflict exists over their effects on bone and mineral metabolism. We measured bone mineral density (BMD), bone turnover markers, and adrenal steroid hormones in 53 patients (34 female, 19 male) with chronic bronchial asthma who had taken either inhaled beclomethasone or budesonide in doses of > or = 1500 microg/day for at least 12 months to determine pathogenetic mechanisms of bone loss. To account for the effect of prior oral glucocorticoid exposure we divided patients into two groups: one with (OG) and the other without (IG) a past history of maintenance (> 1 month) oral glucocorticoid therapy. Lumbar spine (LS) and proximal femur BMDs were approximately 1 SD lower in men and women taking OG or high-dose IG for chronic bronchial asthma, potentially equivalent to a doubling of the risk of fracture at these sites. Prior exposure to OG in women was also associated with lower LS and proximal femur BMDs, while men were more sensitive to the adverse effects of IG on LS and Ward's triangle BMDs. Bone formation markers were decreased; however, bone resorption marker concentrations were normal. All patients had evidence of suppression of both endogenous glucocorticoid and adrenal androgen production. Both total duration of OG and biochemical bone turnover marker concentrations were negatively related to proximal femur and rib BMDs and total body bone mineral content, but not to LS BMD. These were stronger for bone resorption markers. Uncoupling of ongoing normal bone resorption from suppressed bone formation may therefore contribute to glucocorticoid-associated bone loss in asthma. Adrenal androgen suppression may also increase the susceptibility of postmenopausal women in particular to bone loss with OG. Although the effects of high-dose IG on BMD are associated with lower LS BMD in men, this observation should now be investigated further in prospective studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9718197     DOI: 10.1359/jbmr.1998.13.8.1283

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

Review 1.  Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.

Authors:  John T Schousboe; Douglas C Bauer
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial.

Authors:  C F McDonald; R M D Zebaze; E Seeman
Journal:  Osteoporos Int       Date:  2006-07-11       Impact factor: 4.507

3.  The determinants of bone mineral density in Chinese men--results from Mr. Os (Hong Kong), the first cohort study on osteoporosis in Asian men.

Authors:  E M C Lau; P C Leung; T Kwok; J Woo; H Lynn; E Orwoll; S Cummings; J Cauley
Journal:  Osteoporos Int       Date:  2005-09-21       Impact factor: 4.507

Review 4.  Role of RANKL and RANK in bone loss and arthritis.

Authors:  D Holstead Jones; Y-Y Kong; J M Penninger
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

5.  Lack of bone metabolism side effects after 3 years of nasal topical steroids in children with allergic rhinitis.

Authors:  Ozkaya Emin; Mete Fatih; Dibek Emre; Samanci Nedim
Journal:  J Bone Miner Metab       Date:  2011-02-17       Impact factor: 2.626

6.  Cross-sectional study on bone density-related sonographic parameters in children with asthma: correlation to therapy with inhaled corticosteroids and disease severity.

Authors:  Jochen G Mainz; Dieter Sauner; Ansgar Malich; Stephanie John; Heike Beyermann; Hans-Joachim Mentzel; Werner A Kaiser; Felix Zintl
Journal:  J Bone Miner Metab       Date:  2008-08-30       Impact factor: 2.626

7.  Data mining for identifying novel associations and temporal relationships with Charcot foot.

Authors:  Michael E Munson; James S Wrobel; Crystal M Holmes; David A Hanauer
Journal:  J Diabetes Res       Date:  2014-04-27       Impact factor: 4.011

Review 8.  The risk of osteoporosis in patients with asthma.

Authors:  Indumathi Kumarathas; Torben Harsløf; Charlotte Uggerhøj Andersen; Bente Langdahl; Ole Hilberg; Leif Bjermer; Anders Løkke
Journal:  Eur Clin Respir J       Date:  2020-05-19

9.  Reduced bone mineral density in male Severe Acute Respiratory Syndrome (SARS) patients in Hong Kong.

Authors:  E M C Lau; F W K Chan; D S C Hui; A K L Wu; P C Leung
Journal:  Bone       Date:  2005-09       Impact factor: 4.398

10.  Self-reported osteoporosis prevention in inhaled corticosteroid users in community pharmacy setting.

Authors:  Valerie Chan; Andrew J Cave; Hoan Linh Banh
Journal:  SAGE Open Med       Date:  2015-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.